European Antibiotics Market Assessment and Forecast to 2027 with Profiles of GlaxoSmithKline, Sanofi, Novartis, Bayer and Pfizer - ResearchAndMarkets.com

The "Europe Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country" report has been added to ResearchAndMarkets.com's offering.

The European antibiotics market is expected to reach US$ 15,569.8 million by 2027 from US$ 12,457.7 million in 2019. The market is estimated to grow with a CAGR of 3.1% from 2020 to 2027.

The antibiotics market is growing primarily due to prevalence of infectious diseases and increasing development of generic drugs in The European region that are boosting the market over the years. Restraining factors, such as tedious and expensive process of antibiotic development is likely to slow down the growth of the market in the coming years. Additionally, growing investments to combat antimicrobial resistance and incorporation of novel computing technologies for antibiotics discovery are likely to increase the growth of the antibiotics market in the forecast period.

Generic versions are introduced in the market with an aim to offer cost-efficient drugs and increase the reach of these drugs to people belonging to different economic classes. Generic versions are popular due to their availability and affordability. Additionally, the companies are focusing on development of generic versions to offer antibiotics at minimal costs. Also, pressure to control pharmaceutical expenditure and price competition among pharmaceutical companies are fueling the development of generic medicines markets in Europe. Therefore, generic manufacturers with low production costs, broad portfolios, and stable supplies would witness a robust market growth. Thus, the above factors are likely to drive the growth of antibiotic market in the forecasted period.

Europe has been massively hit by COVID-19 outbreak affecting many of its countries on a large scale. Italy, Germany, Spain, the UK, and France along with other European countries are continually witnessing rise in number of COVID-19 cases every day. In March 2020, European Medicines Agency has formed an executive committee to deal with impact of COVID-19 on supply chain of medicines. According to a data published in a newsletter in March 2020, majority of the European pharmaceutical companies has its manufacturing facilities located in India, while an estimated 70% of the raw ingredients comes from China. This whole supply chain is likely to hamper due to industrial shutdowns, which will ultimately hamper the growth of the market.

In 2019, the cephalosporin segment accounted for the largest share of the market; it is further expected to continue its dominance during the forecast period. This class of antibiotics is usually safe due to low toxicity to self-cells and remarkable efficiency against susceptible bacteria. On the other hand, fluoroquinolones are expected to register the highest CAGR in the antibiotics market during 2020-2027.

Key Topics Covered

1. Introduction

1.1 Scope of the Study

1.2 Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Antibiotics Market - By Drug Class

1.3.2 Europe Antibiotics Market - By Action Mechanism

1.3.3 Europe Antibiotics Market - By Country

2. Europe Antibiotics Market - Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Europe Antibiotics Market - Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Antibiotics Market - Europe PEST Analysis

4.3 Expert Opinion

5. Europe Antibiotics Market - Key Market Dynamics

5.1 Key Market Drivers

5.1.1 Rising Prevalence of Bacterial Infections

5.1.2 Increasing Development of Generic Drugs

5.2 Key Market Restraints

5.2.1 Tedious and Expensive Process of Antibiotic Development

5.3 Market Opportunities

5.3.1 Growing Investments to Combat Antimicrobial Resistance

5.4 Future Trends

5.4.1 Incorporation of Novel Computing Technologies for Antibiotics Discovery

5.5 Impact analysis

6. Antibiotics Market - Europe Analysis

7. Europe Antibiotics Market Analysis and Forecasts to 2027 - By Drug Class

7.1 Overview

7.2 Europe Antibiotics market, By Drug Class 2019 & 2027 (%)

7.3 Sulfonamides

7.4 Aminoglycosides

7.5 Carbapenem

7.6 Macrolides

7.7 Fluoroquinolones

7.8 Penicillin

7.9 Cephalosporins

7.10 Others

8. Europe Antibiotics Market Analysis and Forecasts to 2027 - By Action Mechanism

8.1 Overview

8.2 Europe Antibiotics Market, By Action Mechanism 2019-2027 (%)

8.3 Mycolic Acid Inhibitors

8.4 RNA Synthesis Inhibitors

8.5 DNA Synthesis Inhibitors

8.6 Protein Synthesis Inhibitors

8.7 Cell Wall Synthesis Inhibitors

8.8 Others

9. Antibiotics Market Revenue and Forecasts to 2027 - Geographical Analysis

10. Impact of COVID-19 Pandemic on Europe Antibiotics Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Company Profiles

11.1 GlaxoSmithKline plc

11.2 Sanofi

11.3 Novartis AG

11.4 Bayer AG

11.5 Pfizer Inc.

For more information about this report visit https://www.researchandmarkets.com/r/3hhn34

View source version on businesswire.com: https://www.businesswire.com/news/home/20200702005184/en/